Next Article in Journal
Emerging Roles of Lipophagy in Cancer Metastasis
Previous Article in Journal
Circular RNA hsa_circ_0062682 Binds to YBX1 and Promotes Oncogenesis in Hepatocellular Carcinoma
Previous Article in Special Issue
Current Progress of CAR-NK Therapy in Cancer Treatment
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 14
Issue 18
10.3390/cancers14184525
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Correction to Cancers 2021, 13(23), 6109.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Zhang et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. Cancers 2021, 13, 6109

by
Dongyu Zhang
1,2,†,
Neil J. Shah
3,†,
Michael Cook
4,
Matthew Blackburn
4,
Michael T. Serzan
4,
Shailesh Advani
5,6,
Arnold L. Potosky
7,
Subha Madhavan
7,8,
Anas Belouali
7,8,
Michael B. Atkins
5,7,* and
Dejana Braithwaite
1,2,9,*
1
Department of Epidemiology, College of Public Health and Health Professions, University of Florida, Gainesville, FL 32610, USA
2
University of Florida Health Cancer Center, Gainesville, FL 32610, USA
3
Department of Medicine, Solid Tumor Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
4
Department of Medicine, Division of Hematology/Oncology MedStar Georgetown University Hospital, Washington, DC 20007, USA
5
Department of Oncology, School of Medicine, Georgetown University, Washington, DC 20007, USA
6
Transplant Education Research Center, Terasaki Institute of Biomedical Innovation, Los Angeles, CA 90024, USA
7
Georgetown Lombardi Comprehensive Cancer Center, Washington, DC 20057, USA
8
Innovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC 20007, USA
9
Department of Surgery, University of Florida, Gainesville, FL 32610, USA
*
Authors to whom correspondence should be addressed.
†
These authors have contributed equally to this work as co-first authors.
Cancers 2022, 14(18), 4525; https://doi.org/10.3390/cancers14184525
Submission received: 18 July 2022 / Accepted: 7 September 2022 / Published: 19 September 2022
(This article belongs to the Special Issue Cancer Immunotherapy and Immune-Related Adverse Events)
Versions Notes

Addition of Authors

Subha Madhavan (S.M.) and Anas Belouali (A.B.) were not included as authors in the published article [1]. The corrected Author Contributions Statement appears below. Subha Madhavan should be listed as the eighth author, between Arnold L. Potosky and Anas Belouali, and be affiliated with the “Georgetown Lombardi Comprehensive Cancer Center” and “Innovation Center for Biomedical Informatics, Georgetown University Medical Center” (affiliation number 7 and 8). Anas Belouali should be listed as the ninth author, between Subha Madhavan and Michael B. Atkins, and be affiliated with the “Georgetown Lombardi Comprehensive Cancer Center” and “Innovation Center for Biomedical Informatics, Georgetown University Medical Center” (affiliation number 7 and 8).
S.M. and A.B. made substantial contributions to this manuscript. S.M. and A.B. contributed to data curation and cleaning, database maintenance, and editing and review of the manuscript. S.M. also contributed to funding acquisition.

Additional Affiliation

The affiliation 8 is newly added:
8 Innovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC 20007, USA
The affiliation 9 should be updated to:
9 Department of Surgery, University of Florida, Gainesville, FL 32610, USA
Author Contributions: Conceptualization, D.Z. and D.B.; methodology, D.Z.; software, D.Z.; validation, D.Z., N.J.S., S.A., A.L.P., M.B.A. and D.B.; formal analysis, D.Z.; investigation, D.Z. and N.J.S.; resources, S.M., A.B. and M.B.A.; data curation, S.M., A.B., N.J.S. and M.B.A.; writing—original draft preparation, D.Z.; writing—review and editing, D.Z., N.J.S., M.C., M.B., M.T.S., S.A., A.L.P., S.M., A.B., M.B.A. and D.B.; visualization, D.Z.; supervision, M.B.A. and D.B.; funding acquisition, S.M. and M.B.A. All authors have read and agreed to the published version of the manuscript.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original article has been updated.

Reference

  1. Zhang, D.; Shah, N.J.; Cook, M.; Blackburn, M.; Serzan, M.T.; Advani, S.; Potosky, A.L.; Madhavan, S.; Belouali, A.; Atkins, M.B.; et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. Cancers 2021, 13, 6109. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Zhang, D.; Shah, N.J.; Cook, M.; Blackburn, M.; Serzan, M.T.; Advani, S.; Potosky, A.L.; Madhavan, S.; Belouali, A.; Atkins, M.B.; et al. Correction: Zhang et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. Cancers 2021, 13, 6109. Cancers 2022, 14, 4525. https://doi.org/10.3390/cancers14184525

AMA Style

Zhang D, Shah NJ, Cook M, Blackburn M, Serzan MT, Advani S, Potosky AL, Madhavan S, Belouali A, Atkins MB, et al. Correction: Zhang et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. Cancers 2021, 13, 6109. Cancers. 2022; 14(18):4525. https://doi.org/10.3390/cancers14184525

Chicago/Turabian Style

Zhang, Dongyu, Neil J. Shah, Michael Cook, Matthew Blackburn, Michael T. Serzan, Shailesh Advani, Arnold L. Potosky, Subha Madhavan, Anas Belouali, Michael B. Atkins, and et al. 2022. "Correction: Zhang et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. Cancers 2021, 13, 6109" Cancers 14, no. 18: 4525. https://doi.org/10.3390/cancers14184525

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop